We are thrilled to announce that on April 2, 2019, the Vrije Universiteit Brussel (VUB) will award a joint honorary doctorate for scientific excellence to Susie Durie, IMF President and Co-founder, and Brian G.M. Durie, MD, IMF Chairman and Co-founder, at a ceremony in Brussels, Belgium. 

Dr. Brian G.M. Durie will focus on early disease management including criteria for diagnosis and best treatment options. Patients are increasingly diagnosed early and must be certain if decisive first therapy is appropriate or if observation is recommended. With the introduction of new therapies, there are many options to be reviewed and considered for patients in each risk group, including assessment for age and comorbidities. Current best treatment guidelines will be presented.

Our volunteer fundraisers help raise multiple myeloma awareness in their communities while raising much needed funding for our essential research, patient education, support, and advocacy programs.

A Boston data scientist’s new Twitter account calls out media for touting early research results. A headline like “Scientists Uncover a Protein That Seems to Fight Aging in Our Skin” is legit, for example, if by “our” you mean “mice.” IMF Chairman Brian G.M. Durie, MD has always warned: “Be cautious about early laboratory results. No matter how exciting, they just might not apply in the clinic.”

In this week’s video, Dr. Brian G.M. Durie discusses the main types of imaging studies for myeloma patients, including MRIs, whole-body low-dose CT scans, and PET/CT scans.